• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过使用抗生素去除珠粒消除喹诺酮类抗生素残留

Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.

作者信息

Zabinski R A, Larsson A J, Walker K J, Gilliland S S, Rotschafer J C

机构信息

Miles Inc., West Haven, Connecticut 06516-4175.

出版信息

Antimicrob Agents Chemother. 1993 Jun;37(6):1377-9. doi: 10.1128/AAC.37.6.1377.

DOI:10.1128/AAC.37.6.1377
PMID:8328791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC187972/
Abstract

To prove the utility of antibiotic-removal beads in separating antibiotics from bacterial samples, Escherichia coli ATCC 25922 was exposed to five separate quinolones before and after each was exposed to antibiotic-removal beads. Plates treated with antibiotic solutions that were exposed to beads demonstrated antibiotic removal, and plates treated with antibiotic solutions that were not exposed to beads demonstrated antibiotic carryover. After exposure to beads, fluoroquinolone concentrations decreased from 5 micrograms/ml to 0.14 micrograms/ml (ciprofloxacin), 0.04 micrograms/ml (temafloxacin), < 0.01 microgram/ml (ofloxacin), < 0.01 microgram/ml (sparfloxacin), and 0.02 micrograms/ml (clinafloxacin). These data indicate that antibiotic carryover can be successfully circumvented through the use of antibiotic-removal beads.

摘要

为证明抗生素去除珠在从细菌样本中分离抗生素方面的效用,在将大肠埃希菌ATCC 25922分别暴露于五种喹诺酮类药物前后,均使其接触抗生素去除珠。用接触过珠子的抗生素溶液处理的平板显示抗生素被去除,而用未接触珠子的抗生素溶液处理的平板显示有抗生素残留。接触珠子后,氟喹诺酮类药物浓度从5微克/毫升降至0.14微克/毫升(环丙沙星)、0.04微克/毫升(替马沙星)、<0.01微克/毫升(氧氟沙星)、<0.01微克/毫升(司帕沙星)和0.02微克/毫升(克林沙星)。这些数据表明,通过使用抗生素去除珠可成功避免抗生素残留。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c61/187972/ade80c4f254f/aac00028-0190-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c61/187972/ade80c4f254f/aac00028-0190-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c61/187972/ade80c4f254f/aac00028-0190-a.jpg

相似文献

1
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.通过使用抗生素去除珠粒消除喹诺酮类抗生素残留
Antimicrob Agents Chemother. 1993 Jun;37(6):1377-9. doi: 10.1128/AAC.37.6.1377.
2
Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones.需氧和厌氧环境对五种氟喹诺酮类药物抗葡萄球菌活性的影响
Antimicrob Agents Chemother. 1995 Feb;39(2):507-12. doi: 10.1128/AAC.39.2.507.
3
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.青霉素敏感和耐药肺炎链球菌菌株对RP 59500、万古霉素、红霉素、PD 131628、司帕沙星、替马沙星、win 57273、氧氟沙星和环丙沙星的敏感性。
Antimicrob Agents Chemother. 1992 Apr;36(4):856-9. doi: 10.1128/AAC.36.4.856.
4
Resistance to fluoroquinolones in Escherichia coli isolated from poultry.从家禽中分离出的大肠杆菌对氟喹诺酮类药物的耐药性。
Antimicrob Agents Chemother. 1996 Jun;40(6):1504-7. doi: 10.1128/AAC.40.6.1504.
5
Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure.司帕沙星暴露后脆弱拟杆菌对氟喹诺酮类药物的耐药性
Antimicrob Agents Chemother. 1999 Sep;43(9):2251-5. doi: 10.1128/AAC.43.9.2251.
6
Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).对新型氟喹诺酮类药物DU-6859a与六种结构相似的化合物(环丙沙星、克林沙星、氟罗沙星、左氧氟沙星、氧氟沙星和司帕沙星)进行交叉耐药性分析。
Diagn Microbiol Infect Dis. 1995 Jan;21(1):51-4. doi: 10.1016/0732-8893(94)00116-e.
7
Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones.用各种喹诺酮类药物治疗的亚致死剂量照射小鼠的造血功能增强。
Eur J Haematol. 1997 Feb;58(2):92-8. doi: 10.1111/j.1600-0609.1997.tb00930.x.
8
Comparative in vitro activities of new quinolones against coryneform bacteria.新型喹诺酮类药物对棒状杆菌的体外活性比较
Antimicrob Agents Chemother. 1994 Jun;38(6):1439-41. doi: 10.1128/AAC.38.6.1439.
9
Evaluation of the bactericidal activity of temafloxacin.替马沙星杀菌活性的评估。
Am J Med. 1991 Dec 30;91(6A):31S-34S. doi: 10.1016/0002-9343(91)90307-j.
10
In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.新型二氟喹诺酮类药物司帕沙星(AT - 4140)对结核分枝杆菌的体外活性与氧氟沙星和环丙沙星活性的比较
Antimicrob Agents Chemother. 1991 Sep;35(9):1933-6. doi: 10.1128/AAC.35.9.1933.

引用本文的文献

1
SPS-neutralization in tissue samples for efficacy testing of antimicrobial peptides.组织样本中 SPS 的中和作用,用于抗菌肽的疗效测试。
BMC Infect Dis. 2019 Dec 30;19(1):1093. doi: 10.1186/s12879-019-4700-1.
2
Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin.肺炎链球菌对氟喹诺酮类药物的耐药性:浓度-时间曲线下面积与最低抑菌浓度比值以及加替沙星、吉米沙星、左氧氟沙星和莫西沙星导致的耐药性发展情况
Antimicrob Agents Chemother. 2007 Apr;51(4):1315-20. doi: 10.1128/AAC.00646-06. Epub 2007 Feb 12.
3

本文引用的文献

1
In vitro evaluation of the BACTEC resin-containing blood culture bottle.含BACTEC树脂血培养瓶的体外评估
J Clin Microbiol. 1983 Jun;17(6):1120-6. doi: 10.1128/jcm.17.6.1120-1126.1983.
2
Importance of minimizing carry-over effect at subculture in the detection of penicillin-tolerant viridans group streptococci.在检测耐青霉素的草绿色链球菌时,传代培养时尽量减少残留效应的重要性。
Antimicrob Agents Chemother. 1983 Apr;23(4):614-6. doi: 10.1128/AAC.23.4.614.
3
Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy.
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.
在体外药效学模型中,将利奈唑胺和万古霉素单独及与利福平联合使用,与莫西沙星相比,用于对抗一株耐多药和耐万古霉素的肺炎链球菌菌株。
Antimicrob Agents Chemother. 2003 Jun;47(6):1984-7. doi: 10.1128/AAC.47.6.1984-1987.2003.
4
Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions.在需氧和厌氧条件下的体外模型中,三种新型氟喹诺酮类药物对六种葡萄球菌菌株的比较药效学研究。
Antimicrob Agents Chemother. 2002 May;46(5):1561-3. doi: 10.1128/AAC.46.5.1561-1563.2002.
5
Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model.在体外药效学模型中曲伐沙星和左氧氟沙星对脆弱拟杆菌的药效学研究
Antimicrob Agents Chemother. 2002 Jan;46(1):203-10. doi: 10.1128/AAC.46.1.203-210.2002.
6
Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication.加替沙星在体外药代动力学模型中对肺炎链球菌的药效学:曲线下面积与最低抑菌浓度比值对根除的影响
Antimicrob Agents Chemother. 2002 Jan;46(1):69-74. doi: 10.1128/AAC.46.1.69-74.2002.
7
Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents.在含有抗菌剂的莱姆病患者血清中检测杀博氏疏螺旋体抗体。
Clin Diagn Lab Immunol. 1999 Nov;6(6):930-3. doi: 10.1128/CDLI.6.6.930-933.1999.
8
Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure.司帕沙星暴露后脆弱拟杆菌对氟喹诺酮类药物的耐药性
Antimicrob Agents Chemother. 1999 Sep;43(9):2251-5. doi: 10.1128/AAC.43.9.2251.
9
Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model.利用三株铜绿假单胞菌和体外药效学模型,将24小时浓度-时间曲线下面积与最低抑菌浓度之比作为氟喹诺酮类抗菌效果的一般预测指标。
Antimicrob Agents Chemother. 1996 Mar;40(3):627-32. doi: 10.1128/AAC.40.3.627.
10
Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones.需氧和厌氧环境对五种氟喹诺酮类药物抗葡萄球菌活性的影响
Antimicrob Agents Chemother. 1995 Feb;39(2):507-12. doi: 10.1128/AAC.39.2.507.
对在羟羧氧酰胺菌素治疗中失败或复发的脑膜炎患者的革兰氏阴性杆菌进行检测。
Antimicrob Agents Chemother. 1984 Dec;26(6):850-6. doi: 10.1128/AAC.26.6.850.
4
Evaluation of new blood culture processing systems.新型血培养处理系统的评估
J Clin Microbiol. 1984 Sep;20(3):351-6. doi: 10.1128/jcm.20.3.351-356.1984.
5
Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.通过时间杀菌动力学研究确定人血清对达托霉素和万古霉素针对葡萄球菌和肠球菌分离株的杀菌活性的影响。
Diagn Microbiol Infect Dis. 1990 May-Jun;13(3):245-52. doi: 10.1016/0732-8893(90)90067-6.
6
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.在体外感染模型中,一日一次的阿米卡星与头孢吡肟、氨曲南和头孢他啶以各种组合联用对铜绿假单胞菌的药效学研究。
Antimicrob Agents Chemother. 1992 Dec;36(12):2741-6. doi: 10.1128/AAC.36.12.2741.